Advertisement

Fall Clinical Dermatology Conference 2023: Psoriasis

From Agent to Agent, Interleukin Inhibitors Offer Distinct Benefits in Psoriasis

Nov 16, 2023

REFERENCES & ADDITIONAL READING

Drug Survival and Clinical Effectiveness of Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab, Tildrakizumab for Psoriasis Treatment
https://onlinelibrary.wiley.com/doi/10.1111/ddg.15251

ABOUT THE EXPERTS

  • Simone Ribero, MD, PhD

    University of Turin
    Italy

     

    Simone Ribero, MD, PhD, has indicated to Physician’s Weekly that he has no financial interests to disclose.

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement